DVA240816P120000
- 0.15
- -0.05-25.00%
DaVita Newsroom
Maintain Position on DaVita: A Balanced View of Strong Performance and Future Caution
Express News | DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering
Key Takeaways From DaVita Analyst Ratings
DaVita Is Maintained at Buy by UBS
DaVita Inc. Announces Offering of $1.0 Billion Senior Notes
Express News | B of A Securities Maintains Underperform on DaVita, Raises Price Target to $145
DaVita Analyst Ratings
DaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up
Analysts Have Conflicting Sentiments on These Healthcare Companies: Organon (OGN), Stevanato Group (STVN) and DaVita (DVA)
Bank of America Securities Sticks to Its Sell Rating for DaVita (DVA)
Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
Barclays Keeps Their Hold Rating on DaVita (DVA)
DaVita Lifts Annual Profit Forecast on Strong Kidney Dialysis Services Demand
DaVita | 10-Q: Q2 2024 Earnings Report
Express News | DaVita Inc Sees FY Adjusted Diluted Net Income per Share Attributable to DaVita Inc. $9.25- $10.05
Express News | DaVita Inc: During First Half of 2024, We Experienced Delays in Claims Processing as a Result of Change Healthcare Outage
Express News | DaVita Inc: Applied for and Received Interest-Free Funding From UnitedHealth Group Under Temporary Funding Assistance Program
DaVita Raises FY24 EPS Guidance From $9.00-$9.80 To $9.25-$10.05 Vs $9.32 Est.
DaVita HealthCare: Q2 Earnings Snapshot
Express News | DaVita Q2 Adjusted EPS USD 2.59 Vs. IBES Estimate USD 2.54